Search Results

There are 3455 results for: content related to: Consequences of Long-Term Proton Pump Blockade: Insights from Studies of Patients with Gastrinomas

  1. You have free access to this content
    Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas

    Alimentary Pharmacology & Therapeutics

    Volume 16, Issue 7, July 2002, Pages: 1367–1382, S. Bashir, F. Gibril, J. V. Ojeaburu, B. Asgharian, L. K. Entsuah, G. Ferraro, P. Crafa, C. Bordi and R. T. Jensen

    Version of Record online : 25 JUL 2002, DOI: 10.1046/j.1365-2036.2002.01249.x

  2. The regulation of gastric acid secretion – clinical perspectives

    Acta Physiologica

    Volume 210, Issue 2, February 2014, Pages: 239–256, H. L. Waldum, Ø. Hauso and R. Fossmark

    Version of Record online : 27 DEC 2013, DOI: 10.1111/apha.12208

  3. You have free access to this content
    Personal review: is profound acid inhibition safe?

    Alimentary Pharmacology & Therapeutics

    Volume 14, Issue 1, January 2000, Pages: 15–22, Waldum and Brenna

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.2000.00681.x

  4. You have free access to this content
    Review article: pathogenesis and management of gastric carcinoid tumours

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 9, November 2006, Pages: 1305–1320, M. D. BURKITT and D. M. PRITCHARD

    Version of Record online : 16 OCT 2006, DOI: 10.1111/j.1365-2036.2006.03130.x

  5. Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis

    European Journal of Clinical Investigation

    Volume 20, Issue 1, February 1990, Pages: 65–71, R. HÅKANSON and F. SUNDLER

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2362.1990.tb01780.x

  6. You have free access to this content
    Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia

    Alimentary Pharmacology & Therapeutics

    Volume 26, Issue 6, September 2007, Pages: 869–878, B. I. HIRSCHOWITZ, J. WORTHINGTON, J. MOHNEN and M. HABER

    Version of Record online : 12 JUL 2007, DOI: 10.1111/j.1365-2036.2007.03439.x

  7. You have full text access to this OnlineOpen article
    Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 6, September 2015, Pages: 649–663, L. Lundell, M. Vieth, F. Gibson, P. Nagy and P. J. Kahrilas

    Version of Record online : 16 JUL 2015, DOI: 10.1111/apt.13324

  8. You have free access to this content
    Review article: the investigation and management of gastric neuroendocrine tumours

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 10, May 2014, Pages: 1071–1084, R. Basuroy, R. Srirajaskanthan, A. Prachalias, A. Quaglia and J. K. Ramage

    Version of Record online : 13 MAR 2014, DOI: 10.1111/apt.12698

  9. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats

    APMIS

    Volume 113, Issue 6, June 2005, Pages: 436–449, REIDAR FOSSMARK, CHUN-MEI ZHAO, TOM C. MARTINSEN, SHIRO KAWASE, DUAN CHEN and HELGE L. WALDUM

    Version of Record online : 30 JUN 2005, DOI: 10.1111/j.1600-0463.2005.apm_134.x

  10. Morphological, molecular, and prognostic aspects of gastric endocrine tumors

    Microscopy Research and Technique

    Volume 48, Issue 6, 15 March 2000, Pages: 339–348, Enrico Solcia, Guido Rindi, Stefano Larosa and Carlo Capella

    Version of Record online : 29 MAR 2000, DOI: 10.1002/(SICI)1097-0029(20000315)48:6<339::AID-JEMT4>3.0.CO;2-D

  11. You have free access to this content
    Gastric carcinoids after long-term use of a proton pump inhibitor

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 7, October 2012, Pages: 644–649, C. S. Jianu, R. Fossmark, T. Viset, G. Qvigstad, Ø. Sørdal, R. Mårvik and H. L. Waldum

    Version of Record online : 5 AUG 2012, DOI: 10.1111/apt.12012

  12. You have free access to this content
    Effect of netazepide, a gastrin/CCK2 receptor antagonist, on gastric acid secretion and rabeprazole-induced hypergastrinaemia in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 79, Issue 5, May 2015, Pages: 744–755, Malcolm Boyce, Sally Dowen, Gillian Turnbull, Frans van den Berg, Chun-Mei Zhao, Duan Chen and James Black

    Version of Record online : 22 APR 2015, DOI: 10.1111/bcp.12534

  13. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: A study by elutriation centrifugation

    Acta Physiologica Scandinavica

    Volume 169, Issue 1, May 2000, Pages: 29–37, Bakke, Qvigstad, Brenna, Sandvik and Waldum

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-201x.2000.00688.x

  14. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy

    European Journal of Clinical Investigation

    Volume 31, Issue 9, September 2001, Pages: 802–811, S. Sanduleanu, A. De Bruïne, M. Stridsberg, D. Jonkers, I. Biemond, W. Hameeteman, G. Lundqvist and R. W. Stockbrügger

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2362.2001.00890.x

  15. You have free access to this content
    Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 11-12, December 2012, Pages: 1067–1075, R. Fossmark, Ø. Sørdal, C. S. Jianu, G. Qvigstad, I. S. Nordrum, M. Boyce and H. L. Waldum

    Version of Record online : 16 OCT 2012, DOI: 10.1111/apt.12090

  16. G-cell hyperplasia of the stomach induces ECL-cell proliferation in the pyloric glands in a paracrinal manner

    Pathology International

    Volume 65, Issue 5, May 2015, Pages: 259–263, Atsuko Kasajima, Fumiyoshi Fujishima, Takanori Morikawa, Shuhei Kawasaki, Sachiko Konosu-Fukaya, Yukiko Shibahara, Tadaho Nakamura, Takeo Yoshikawa, Katsunori Iijima, Tomoyuki Koike, Mika Watanabe, Chikashi Shibata and Hironobu Sasano

    Version of Record online : 2 MAR 2015, DOI: 10.1111/pin.12276

  17. You have free access to this content
    Rebound Hypersecretion after Inhibition of Gastric Acid Secretion

    Basic & Clinical Pharmacology & Toxicology

    Volume 94, Issue 5, May 2004, Pages: 202–208, Gunnar Qvigstad and Helge Waldum

    Version of Record online : 5 MAY 2004, DOI: 10.1111/j.1742-7843.2004.pto940502.x

  18. Effects on the rat oxyntic mucosa of the histamine2-antagonist loxtidine and the H+, K+-ATPase inhibitor omepvazole

    Alimentary Pharmacology & Therapeutics

    Volume 6, Issue 3, June 1992, Pages: 335–349, E. BRENNA, H. L. WALDUM, A. K. SANDVIK, B. SCHULZE SØGNEN and A. KRISTENSEN

    Version of Record online : 31 MAR 2007, DOI: 10.1111/j.1365-2036.1992.tb00055.x

  19. Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival

    APMIS

    Volume 123, Issue 6, June 2015, Pages: 509–514, Reidar Fossmark, Liv Sagatun, Ivar S. Nordrum, Arne K. Sandvik and Helge L Waldum

    Version of Record online : 5 MAY 2015, DOI: 10.1111/apm.12380

  20. You have free access to this content
    Involvement of Cholecystokinin/Gastrin-Related Peptides and their Receptors in Clinical Gastrointestinal Disorders

    Pharmacology & Toxicology

    Volume 91, Issue 6, December 2002, Pages: 333–350, Robert T. Jensen

    Version of Record online : 28 JAN 2003, DOI: 10.1034/j.1600-0773.2002.910611.x